Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Nasdaq 100 Slips Below 29,000 as Tech Rally Falters
Markets Daniel Marsh

Nasdaq 100 Slips Below 29,000 as Tech Rally Falters

The Nasdaq 100 dropped below 29,000 on Monday, closing at 28,880.80, as chip and AI stocks lost momentum. Nvidia's earnings on Wednesday are the next key catalyst.

NVDA AMD INTC MU SMH QQQ
Dow Edges Higher as Treasury Yields Retreat, Bond Warning Persists
Markets Daniel Marsh

Dow Edges Higher as Treasury Yields Retreat, Bond Warning Persists

The Dow Jones rose 0.22% on Monday as Treasury yields eased, but bond market warnings remain as oil prices stay elevated. Dominion Energy surged on a $66.8 billion NextEra deal.

DIA SPY QQQ D TLT USO NEE REGN NVDA WMT
Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets
Markets Daniel Marsh

Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets

Stocks were mixed Monday as the Dow edged up but the Nasdaq fell, with bond yields pulling back from recent highs. Dominion Energy jumped on a $66.8B acquisition by NextEra, while Regeneron slid on a trial miss.

DOW SPY QQQ TLT NVDA SOXX D DUK NEE AES CEG REGN WMT HD TGT TJX USO GLD
VTI Attracts $852M Inflows Despite Weekly Decline
Markets Daniel Marsh

VTI Attracts $852M Inflows Despite Weekly Decline

VTI pulled in $852 million in net inflows over five days despite a weekly drop, driven by demand for AI-linked tech stocks and broad market exposure.

VTI NVDA AAPL MSFT QQQ
Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning
Markets Daniel Marsh

Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning

Quince Therapeutics stock trades near $1.15 as the company faces Nasdaq compliance issues, a going concern warning, and a failed Phase 3 trial, with a shareholder vote on a reverse stock split scheduled for June 11.

QNCX
Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market
Markets Daniel Marsh

Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market

Berkshire Hathaway's new 3.04 million share stake in Macy's, valued at $55 million, lifted shares in pre-market. Q1 results are due June 3, with headwinds from tariffs and weak spending.

M BRK.B
Markets Daniel Marsh

Virax Biolabs Surges on TV Segment and Ownership Filing

Virax Biolabs shares surged over 125% in pre-market trading Monday after a sponsored TV segment featuring its CEO and a new SEC filing revealed Armistice Capital holds a 4.99% stake.

VRAX
Hims & Hers Shares Slide on Convertible Note Sale, Dilution Worries
Markets Daniel Marsh

Hims & Hers Shares Slide on Convertible Note Sale, Dilution Worries

Hims & Hers Health shares declined 4% in pre-market trading after announcing a $300 million convertible note sale to finance its Eucalyptus acquisition and technology investments.

HIMS
Huachen AI Parking Surges 82% Premarket on Nasdaq Compliance Hopes
Markets Daniel Marsh

Huachen AI Parking Surges 82% Premarket on Nasdaq Compliance Hopes

Huachen AI Parking Management shares jumped 82% in premarket trading Monday, driven by Nasdaq compliance buzz and a recent reverse stock split. The stock reached $10.10 with volumes far above average.

HCAI
T1 Energy Rises Premarket as Shareholder Vote on Capital Hike Nears
Markets Daniel Marsh

T1 Energy Rises Premarket as Shareholder Vote on Capital Hike Nears

T1 Energy Inc. stock traded up to $6.56 premarket Monday after closing at $5.67 Friday, as the company seeks shareholder approval to double authorized shares to 1 billion for its G2_Austin solar cell plant.

AI Data Center Boom Drives $66.8B NextEra-Dominion Merger
Markets Daniel Marsh

AI Data Center Boom Drives $66.8B NextEra-Dominion Merger

NextEra Energy is buying Dominion Energy for $66.8 billion in stock, forming the largest regulated electric utility globally to power AI data centers.

NEE D SO DUK
GeoVax Shares Surge Pre-Market on Mpox Vaccine Trial Plans
Markets Daniel Marsh

GeoVax Shares Surge Pre-Market on Mpox Vaccine Trial Plans

GeoVax Labs shares surged pre-market Monday after announcing plans for a Phase 3 trial of its GEO-MVA mpox vaccine, though cash and funding risks remain key issues.

GOVX